Surgical Science Sweden AB Market Cap ($323.16 Million)
Market Cap & Net Worth: Surgical Science Sweden AB (SUS)
Surgical Science Sweden AB market cap. Surgical Science Sweden AB (ST:SUS) has a market capitalization of $323.16 Million (Skr3.00 Billion) as of November 1, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #14155 globally and #237 in its home market, demonstrating a 2.44% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Surgical Science Sweden AB's stock price Skr58.85 by its total outstanding shares 51026236 (51.03 Million). Also see Surgical Science Sweden AB cash flow conversion for how efficiently the company converts equity into cash flow.
Surgical Science Sweden AB Market Cap History (2017–2026)
Surgical Science Sweden AB market cap history from 2017 to 2026. Data shows growth from $80.59 Million to $323.16 Million (19.31% CAGR). Check Surgical Science Sweden AB share price for real-time trading data and today's change.
Surgical Science Sweden AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Surgical Science Sweden AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore SUS shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.18x
Surgical Science Sweden AB's market cap is 0.18 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.67x
Surgical Science Sweden AB's market cap is 2.67 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $80.59 Million | $57.98 Million | -$2.26 Million | 1.39x | N/A |
| 2018 | $107.45 Million | $65.70 Million | -$4.52 Million | 1.64x | N/A |
| 2019 | $455.59 Million | $101.52 Million | $12.60 Million | 4.49x | 36.16x |
| 2020 | $502.33 Million | $104.80 Million | $15.61 Million | 4.79x | 32.19x |
| 2021 | $1.52 Billion | $366.78 Million | $86.25 Million | 4.15x | 17.64x |
| 2022 | $897.40 Million | $802.54 Million | $187.97 Million | 1.12x | 4.77x |
| 2023 | $1.00 Billion | $882.85 Million | $233.97 Million | 1.14x | 4.28x |
| 2024 | $856.08 Million | $884.09 Million | $131.65 Million | 0.97x | 6.50x |
| 2025 | $178.47 Million | $992.34 Million | $66.82 Million | 0.18x | 2.67x |
Competitor Companies of SUS by Market Capitalization
Companies near Surgical Science Sweden AB in the global market cap rankings as of November 1, 2026. Also see Surgical Science Sweden AB (SUS) total assets for a full breakdown of the balance sheet.
Key companies related to Surgical Science Sweden AB by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #719 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1627 globally with a market cap of $14.50 Billion USD ( AU$20.50 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2005 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2067 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #719 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $312.96 |
| #1627 | Pro Medicus Ltd | AU:PME | $14.50 Billion | AU$196.20 |
| #2005 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $72.22 |
| #2067 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.89 |
Market Capitalization of Surgical Science Sweden AB (2017–2026)
Market capitalization of Surgical Science Sweden AB from 2017 to today. Between 2017 and today, Surgical Science Sweden AB's market cap moved from $80.59 Million to $ 323.16 Million, with a yearly change of 19.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr323.16 Million | +81.08% |
| 2025 | Skr178.47 Million | -79.15% |
| 2024 | Skr856.08 Million | -14.58% |
| 2023 | Skr1.00 Billion | +11.67% |
| 2022 | Skr897.40 Million | -41.01% |
| 2021 | Skr1.52 Billion | +202.83% |
| 2020 | Skr502.33 Million | +10.26% |
| 2019 | Skr455.59 Million | +324.00% |
| 2018 | Skr107.45 Million | +33.33% |
| 2017 | Skr80.59 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Surgical Science Sweden AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $323.16 Million USD |
| MoneyControl | $323.16 Million USD |
| MarketWatch | $323.16 Million USD |
| marketcap.company | $323.16 Million USD |
| Reuters | $323.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Surgical Science Sweden AB
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquis… Read more